Integrated Filing — IndAS



General information about company
Scrip Code 539871
NSE Symbol THYROCARE
MSEI Symbol NOTLISTED
ISIN INE594H01019
Name of company Thyrocare Technologies Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 23-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 23-Jul-2025   14:15:00
End date and time of board meeting 23-Jul-2025   15:28:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1930300000
Other income 46500000
Total income 1976800000
2 Expenses
(a) Cost of materials consumed 554100000
(b) Purchases of stock-in-trade 700000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 1500000
(d) Employee benefit expense 330000000
(e) Finance costs 7800000
(f) Depreciation, depletion and amortisation expense 114100000
(f) Other Expenses
1 Other expenses 466300000 466300000
Total other expenses 466300000
Total expenses 1474500000
3 Total profit before exceptional items and tax 502300000
4 Exceptional items 0
5 Total profit before tax 502300000
6 Tax expense
7 Current tax 143000000
8 Deferred tax -21100000
9 Total tax expenses 121900000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 380400000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 2500000
16 Total profit (loss) for period 382900000
17 Other comprehensive income net of taxes -2300000
18 Total Comprehensive Income for the period 380600000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 389300000
Total profit or loss, attributable to non-controlling interests -6400000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 387000000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -6400000
21 Details of equity share capital
Paid-up equity share capital 529900000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.35
Diluted earnings (loss) per share from continuing operations 7.33
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.35
Diluted earnings (loss) per share from continuing and discontinued operations 7.33
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Diagnostic Testing Services 1783300000 1783300000
2 Imaging Services 140400000 140400000
3 Others 6600000 6600000
Total Segment Revenue 1930300000
Less: Inter segment revenue 0 0
Revenue from operations 1930300000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Diagnostic Testing Services 448500000 448500000
2 Imaging Services 2700000 2700000
3 Others 4600000 4600000
Total Profit before tax 455800000
i. Finance cost 0 0
ii. Other Unallocable Expenditure net off Unallocable income -46500000 -46500000
Profit before tax 502300000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Diagnostic Testing Services 5183200000 5183200000
2 Imaging Services 1845800000 1845800000
3 Others 0 0
Total Segment Asset 7029000000 7029000000
Un-allocable Assets 347000000 347000000
Net Segment Asset 7376000000 7376000000
4 Segment Liabilities
Segment Liabilities
1 Diagnostic Testing Services 1211200000 1211200000
2 Imaging Services 146100000 146100000
3 Others 0 0
Total Segment Liabilities 1357300000 1357300000
Un-allocable Liabilities 91800000 91800000
Net Segment Liabilities 1449100000 1449100000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit (liability)/asset -3000000 -3000000
Total Amount of items that will not be reclassified to profit and loss -3000000
2 Income tax relating to items that will not be reclassified to profit or loss -700000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -2300000